FedEx Collaborates with Korea Medical Devices Industry Association (KMDIA) to Accelerate Global Expansion of Korean Medical Exporters

SEOUL, South Korea, April 7, 2026 — Federal Express Corporation (FedEx), one of the world’s largest express transportation companies, today announced a collaboration with the Korea Medical Devices Industry Association (KMDIA) to support Korean medical device manufacturers and exporters as they expand their global presence.

Representing about 1,100 member companies – accounting for more than 70% of Korea’s total medical device exports, KMDIA plays a pivotal role in advancing the global competitiveness of Korea’s medical device industry. Through this collaboration, FedEx aims to strengthen export readiness and logistics capabilities across the sector.

Under the agreement, KMDIA members will benefit from up to 60% discounts on FedEx international shipping services, including FedEx International Priority® Express, FedEx International Priority®, and FedEx International Economy. Leveraging FedEx’s extensive global networks, these services offer fast, reliable, and flexible delivery solutions designed to meet the time-critical and regulatory demands of medical device exporters.

In addition, FedEx will provide exclusive educational webinars and personalized consultations to KMDIA members. These sessions will deliver practical insights on customs clearance, regulatory compliance, and export best practices, empowering manufacturers to optimize supply chains and navigate an increasingly complex global trade environment with greater confidence.

Korea’s medical device industry continues to demonstrate strong momentum, driven by rising global demand for diagnostic reagents, aesthetic laser systems, and rehabilitation equipment. Korea’s biohealth sector is projected to grow by 20.8% to USD 290 billion in 2026—the fastest expansion since 2019—and is expected to reach USD 357 billion by 2029[1]. To further strengthen global competitiveness, the Korean government has announced plans to invest approximately USD 628 million from 2026 to 2032 to accelerate medical device research and development. [2]

“We are excited to collaborate with KMDIA to support Korean medical device manufacturers and exporters as they scale globally,” said Wonbin Park, managing director of FedEx Korea. “With our global network, industry expertise and differentiated logistics solutions, FedEx is well positioned to help K-biohealth compete on the world stage and contribute to the government’s vision of developing medical devices into a new national growth engine.”

FedEx continues to strengthen its healthcare value proposition to meet the specialized needs of the life sciences sector. This includes a global network of six Life Science Centers in Gimpo (South Korea), Singapore, Tokyo (Japan), Mumbai (India), Memphis (USA), and Veldhoven (the Netherlands), supported by more than 130 cold-chain facilities worldwide.

FedEx also operates 22 facilities globally under the IATA Center of Excellence for Independent Validators (CEIV) Pharma quality framework, including certified operations at Guangzhou Baiyun International Airport (CAN) and Kansai International Airport (KIX), ensuring regulatory compliance and product integrity across international healthcare shipments.

Industry-leading solutions such as FedEx Surround® Monitoring and Intervention Solution leverage near-real time sensor data and AI-powered predictive analytics to proactively monitor high-value, time-sensitive shipments - enhancing visibility, risk management, and supply chain resilience for industries including healthcare, aerospace, and automotive.

[1] Korea Health Industry Development Institute (KHIDI): S. Korea’s biohealth industry likely to expand over 20 pct in 2026: report | Yonhap News Agency

[2] Korea to invest 940.8 billion won in advanced medical device R&D over seven years - CHOSUNBIZ